NGM Biopharmaceuticals Financial Health
How is NGM Biopharmaceuticals's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: NGM's short term assets ($315.7M) exceed its short term liabilities ($48.6M).
Long Term Liabilities: NGM's short term assets ($315.7M) exceed its long term liabilities ($1.4M).
Debt to Equity History and Analysis
Debt Level: NGM is debt free.
Reducing Debt: NGM has not had any debt for past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NGM has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NGM has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 35.7% each year